Nusbaum, Stein, Goldstein, Bronstein & Kron, A Professional Corporation

Free Consultation

Hablamos Espanol

Nationwide Class I recall issued for dangerous products

The most serious recall the Food and Drug Administration can issue is a Class I recall. Dangerous products in this class potentially cause severe or fatal injuries to their victims here in New Jersey and elsewhere. The FDA recently issued such a recall for normal saline flush syringes made by Nurse Assist Inc.

The syringes contain a .9 percent sodium chloride solution that cleans out the lines of medical devices that deliver intravenous medications to patients through either a catheter or a needle. The lines are cleared both before and after a medication is administered. Approximately 386,175 syringes distributed across the country, perhaps including some here in New Jersey, are potentially contaminated with Burkholderia cepacia (B. cepacia).

B. cepacia is known to cause infections in the bloodstream. Health care workers using the syringes and patients on whose lines they are being used are at risk of such infections. Patients with weakened immune systems are more susceptible to B. cepacia infections. Unfortunately, a wide range of symptoms is associated with these infections, which makes them more difficult to detect. Health care providers were urged to discontinue using the products in Oct. 2016.

Because the infection is difficult to diagnose, patients could suffer the infection and it might not readily be connected to these dangerous products. Anyone recently diagnosed with a bloodstream infection caused by b. cepacia after receiving medications through a catheter or needle might look into the possibility of filing a products liability claim. Any restitution received from a successful claim could help with the unexpected financial losses and other damages sustained from exposure to this or any other potentially fatal contaminant.

Source:, "Nurse Assist Inc. Recalls Normal Saline Flush IV Syringes Due to Possible Burkholderia Cepacia Bloodstream Infections", Jan. 3, 2017

No Comments

Leave a comment
Comment Information